Results 81 to 90 of about 1,671 (156)

Supplemental Material, Cannabis_PKAN_supplement2 - Cannabis Use in Children With Pantothenate Kinase–Associated Neurodegeneration

open access: yes, 2019
Supplemental Material, Cannabis_PKAN_supplement2 for Cannabis Use in Children With Pantothenate Kinase–Associated Neurodegeneration by Jenny L. Wilson, Allison Gregory, Katrina Wakeman, Alison Freed, Puneet Rai, Colin Roberts, Susan J Hayflick and ...
Puneet Rai (8118617)   +7 more
core   +1 more source

An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria.

open access: yes, 2003
Mutations in the human PANK2 gene have been shown to occur in autosomal-recessive pantothenate kinase-associated neurodegeneration, a syndrome originally described by Hallervorden and Spatz.
Hortnagel, K;Prokisch, H;Meitinger, T
core   +2 more sources

A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients

open access: yesNeurology International, 2018
Pantothenate kinase-associated neurodegeneration (PKAN) is the most common form of neurodegeneration with brain iron accumulation, it is an autosomal recessive disease due to mutation in PANK 2 on chromosome 20, which causes the accumulation of iron in ...
Mohammad Rohani   +3 more
doaj   +1 more source

Supplemental Material, Cannabis_PKAN_supplement1 - Cannabis Use in Children With Pantothenate Kinase–Associated Neurodegeneration

open access: yes, 2019
Supplemental Material, Cannabis_PKAN_supplement1 for Cannabis Use in Children With Pantothenate Kinase–Associated Neurodegeneration by Jenny L. Wilson, Allison Gregory, Katrina Wakeman, Alison Freed, Puneet Rai, Colin Roberts, Susan J Hayflick and ...
Puneet Rai (8118617)   +7 more
core   +1 more source

Coenzyme A corrects pathological defects in human neurons of PANK2‐associated neurodegeneration

open access: yesEMBO Molecular Medicine, 2016
Pantothenate kinase‐associated neurodegeneration (PKAN) is an early onset and severely disabling neurodegenerative disease for which no therapy is available.
Daniel I Orellana   +15 more
doaj   +1 more source

Neurodegeneration with brain iron accumulation for stem-cell therapy: Anesthetic management

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth, 2018
Neurodegeneration with brain iron accumulation (Hallervorden-Spatz Disease) is a rare, slowly progressing disorder characterized by progressive extrapyramidal dysfunction resulting in dementia, dystonia, torticollis, ataxia, kyphoscoliosis, and seizures.
Ruchi A Jain   +2 more
doaj   +1 more source

Pantothenate kinase associated neurodegeneration: Case series

open access: yes, 2021
Background: Neurodegeneration with brain iron accumulation (NBIA) encompasses a heterogeneous group of hereditary disorders characterized by iron deposition particularly in the basal ganglia. Pantothenate kinase‐associated neurodegeneration (PKAN) is the
Rafai , Abdoh Mohamed   +4 more
core  

Atypical pantothenate kinase-associated neurodegeneration with PANK2 mutations : clinical description and a review of the literature

open access: yes, 2020
Panthothenate kinase-associated neurodegeneration (PKAN) is arare neurodegeneration caused by mutations in the pantothenate kinase (PANK2) gene, which is located on chromosome 20p13.
Chenkai Zhu (8734539), Si Pan (3232293)
core   +1 more source

Ataxic gait and dysarthria in a child: pantothenate kinase-associated neurodegeneration as a diagnosis. [PDF]

open access: yesOxf Med Case Reports, 2023
Naggar A   +5 more
europepmc   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Home - About - Disclaimer - Privacy